Futura Medical PLC (AIM:FUM, OTC:FAMDF), the AIM-listed firm behind Eroxon, has appointed Panmure Liberum as its sole broker with immediate effect. The firm, which focuses on sexual health products, confirmed Panmure Liberum will also continue as its Nominated Adviser.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com